Company
ChinaNANJING HAIRUN PHARMACEUTICAL CO., LTD., China – FDA Inspections
Inspection records and compliance data for NANJING HAIRUN PHARMACEUTICAL CO., LTD.. 1 FDA inspection on record, 1 Form 483, last inspected July 10, 2026.
Company Profile
This profile covers NANJING HAIRUN PHARMACEUTICAL CO., LTD. based in China.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected July 10, 2026.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 10, 2026 | Not classified | Human Drugs | 1328100 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Other regulators (1)
- China NMPA · 2 inspections · last March 14, 2016
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Guangdong Blue Treasure Pharmaceuticals Co. Ltd.
Tien (Tianjin) Pharmaceutical Co., Ltd.
BrightGene Pharmaceutical Co., Ltd.
Qilu Pharmaceutical Co., Ltd. (Laoling Site)
Shandong Lixin Pharmaceutical Co., Ltd.
Esteve Huayi Pharmaceutical Co., Ltd.
Suzhou Lixin Pharmaceutical Co. Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Qingdao Jiulong Biopharmaceutical Co. Ltd.
Apicore US LLC
Company Information
Name
NANJING HAIRUN PHARMACEUTICAL CO., LTD.
FEI Number
3038291022
Address
China
Country
China
ID: 112ef024-8680-4b12-8a8e-6942b987cca5